Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
94
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Serum circRNA_100199 is a Prognostic Biomarker in Acute Myeloid Leukemia

Lingqiao YanDepartment of Hematology, the First People’s Hospital of Wenling, Wenling, Zhejiang, 317500, People’s Republic of ChinaView further author information
&
Qingxian YanDepartment of Hematology, the First People’s Hospital of Wenling, Wenling, Zhejiang, 317500, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0009-0002-2659-3441View further author information
ORCID Icon
Pages 4661-4668 | Received 04 Jul 2023, Accepted 13 Sep 2023, Published online: 16 Oct 2023

References

  • Ley TJ, Miller C. Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059–2074.
  • Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet. 2013;381(9865):484–495. doi:10.1016/S0140-6736(12)61727-9
  • Buchner T, Hiddemann W, Schoch C, Haferlach T, Sauerland MC, Heinecke A. Acute myeloid leukaemia (AML): treatment of the older patient. Best Pract Res Clin Haematol. 2001;14(1):139–151. doi:10.1053/beha.2000.0120
  • Kantarjian H, O’Brien S, Cortes J, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer. 2006;106(5):1090–1098. doi:10.1002/cncr.21723
  • Shaffer BC, Gillet JP, Patel C, Baer MR, Bates SE, Gottesman MM. Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resist Updat. 2012;15(1–2):62–69. doi:10.1016/j.drup.2012.02.001
  • Raponi M, Lancet JE, Fan H, et al. A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia. Blood. 2008;111(5):2589–2596. doi:10.1182/blood-2007-09-112730
  • Raponi M, Harousseau JL, Lancet JE, et al. Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia. Clin Cancer Res. 2007;13(7):2254–2260. doi:10.1158/1078-0432.CCR-06-2609
  • Estey EH. Treatment of acute myeloid leukemia. Haematologica. 2009;94(1):10–16. doi:10.3324/haematol.2008.001263
  • Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood. 2005;106(4):1154–1163. doi:10.1182/blood-2005-01-0178
  • Lin SY, Miao YR, Hu FF, et al. A 6-Membrane Protein Gene score for prognostic prediction of cytogenetically normal acute myeloid leukemia in multiple cohorts. J Cancer. 2020;11(1):251–259. doi:10.7150/jca.35382
  • Zeng M, Ding S, Zhang H, Huang Q, Ren Y, Guo P. Predictive value of integrin alpha7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients. J Clin Lab Anal. 2020;34(4):e23151. doi:10.1002/jcla.23151
  • Yan L, Chen YG. Circular RNAs in immune response and viral infection. Trends Biochem Sci. 2020;45(12):1022–1034. doi:10.1016/j.tibs.2020.08.006
  • Ruan Y, Li Z, Shen Y, Li T, Zhang H, Guo J. Functions of circular RNAs and their potential applications in gastric cancer. Expert Rev Gastroenterol Hepatol. 2020;14(2):85–92. doi:10.1080/17474124.2020.1715211
  • Yang F, Fang E, Mei H, et al. Cis-acting circ-CTNNB1 promotes β-Catenin signaling and cancer progression via DDX3-mediated transactivation of YY1. Cancer Res. 2019;79(3):557–571. doi:10.1158/0008-5472.CAN-18-1559
  • Jian X, He H, Zhu J, et al. Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340. Mol Cancer. 2020;19(1):20. doi:10.1186/s12943-020-1134-8
  • Zhang L, Sun D, Zhang J, Tian Y. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis. Life Sci. 2021;266:118829. doi:10.1016/j.lfs.2020.118829
  • Zhang R, Shang L, Nan J, et al. Circ-METTL15 contributes to the proliferation, metastasis, immune escape and restrains apoptosis in lung cancer by regulating miR-1299/PDL1 axis. Autoimmunity. 2022;55(1):8–20. doi:10.1080/08916934.2021.2001801
  • Zhang H, Shen Y, Li Z, et al. The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers. J Clin Lab Anal. 2020;34(1):e23049. doi:10.1002/jcla.23049
  • Li F, Huang Q, Gong Z, Wang H, Chen J. Diagnostic and prognostic roles of circ-SHPRH for solid cancers: a meta-analysis. Onco Targets Ther. 2019;12:4351–4357. doi:10.2147/OTT.S200755
  • Zhang HD, Jiang LH, Sun DW, Hou JC, Ji ZL. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7. doi:10.1007/s12282-017-0793-9
  • Singh V, Uddin MH, Zonder JA, Azmi AS, Balasubramanian SK. Circular RNAs in acute myeloid leukemia. Mol Cancer. 2021;20(1):149. doi:10.1186/s12943-021-01446-z
  • Li H, Bi K, Feng S, Wang Y, Zhu C. CircRNA circ_POLA2 is upregulated in Acute Myeloid Leukemia (AML) and promotes cell proliferation by suppressing the production of mature miR-34a. Cancer Manag Res. 2021;13:3629–3637. doi:10.2147/CMAR.S281690
  • Yi YY, Yi J, Zhu X, et al. Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis. J Cell Physiol. 2019;234(4):3711–3719. doi:10.1002/jcp.27145

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.